Global 3,4-Dihydro-2H-pyran(DHP) Market Strategic Research Report

Scope of the Report

The global 3,4-Dihydro-2H-pyran(DHP) market size is predicted to grow from US$ 46.19 million in 2025 to US$ 54.05 million in 2032; it is expected to grow at a CAGR of 2.3% from 2026 to 2032.

3,4-Dihydro-2H-pyran (DHP) is an organic compound with a molecular formula of C5H8O. It is a cyclic ether with a six-membered ring structure, and is a colorless liquid at room temperature. 3,4-DHP is an important intermediate in the production of some chemical compounds.

The key manufacturers of 3,4-Dihydro-2H-pyran(DHP) in the world are BASF, Kawaken Fine Chemicals, Jiangsu Clent Chemical, Shandong Yino Biologic Materials, QQCHEM, Henan Yuchen Pharmaceutical, Nanjing Hengwang Biomedical and Zouping Mingxing Chemical, among which the top three producers hold over 60% of the market share, with BASF being the largest manufacture. The global production of 3,4-dihydro-2H-pyran is mainly distributed in North America, Europe, China, and Japan, with the top three production regions accounting for over 90% of the market share. In terms of product types, the growth rate of products with purity higher than 98% is relatively fast, and the market share is high, exceeding 80%, followed by products with purity lower than 98%. In terms of its application, pharmaceutical intermediate are the largest application field, occupying over 20% of the market share, followed by hydroxyl group protecting.

This report presents a comprehensive overview of the global 3,4-Dihydro-2H-pyran(DHP) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Above 98% Purity
• Below 98% Purity

Segment by Application

• Pharmaceuticals Intermediate
• Hydroxyl Group Protecting Agent
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global 3,4-Dihydro-2H-pyran(DHP) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceuticals Intermediate, Hydroxyl Group Protecting Agent, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact